Trials Currently Enrolling
Studies listed below are currently or will soon be recruiting patients. Links displaying the  icon will take you to the study listing on clinicaltrials.gov. In some cases, links to additional information (beyond that which is provided on clinicaltrials.gov) are provided.
If you would like to be notified when new trial listings are added, subscribe to the ITN Mailing List.
TYPE 1 DIABETES
The AbATE Type 1 Diabetes Trial - hOKT3g1(Ala-Ala) for new onset diabetes
Conditions: Recently diagnosed type 1 diabetes
Natural History Study of the Development of Type 1 Diabetes (TrialNet)
Conditions: people at increased risk for type 1 diabetes
Oral Insulin for Prevention of Type 1 Diabetes (TrialNet)
Conditions: people at increased risk for type 1 diabetes
The Rituximab Study (TrialNet)
Conditions: Recently diagnosed with type 1 diabetes
OTHER AUTOIMMUNE DISEASES
Psoriatic Arthritis Research and Treatment (PART) Study
Conditions: Psoriatic Arthritis
STAyCIS - Statins (Atorvastatin) for treatment of patients With Clinically Isolated Syndrome and High Risk of Multiple Sclerosis
Conditions: Multiple Sclerosis; Clinically Isolated Syndrome
Rituximab for the Treatment of ANCA-associated vasulitis
Conditions: Wegener's Granulomatosis and Microscopic Polyangiitis
TRANSPLANTATION
Donor Stem Cells and Campath 1H to Prevent Organ Rejection in Kidney Transplantation
Condition: Kidney Transplantation
The ITN Registry of Tolerant Kidney Transplant Recipients
Conditions: Kidney Transplantation
BESTT: Belatacept Efficacy, Safety and Transplant Tolerance
Conditions: Kidney Transplantation
Safety of Withdrawing Immunosuppressive Drugs in Children Who Have Received a Liver Transplant
Conditions: Pediatric Liver Transplantation
Gradual Withdrawal of Immunosuppression in Adult Liver Transplantation
Conditions: Liver Transplantation
ASTHMA/ALLERGY
The LEAP Study: Prevention of peanut allergy in high-risk children with eczema and/or egg allergy 
Conditions: Eczema, egg allergy, peanut allergy
GPAC: Global Prevention of Asthma in Children
Conditions: Eczema, allergy, asthma
Trials no longer enrolling patients
Multicenter trial of the Edmonton Protocol for islet transplantation in Type 1 diabetes mellitus
Principal Investigator: James Shapiro, University of Alberta
A Phase I Study: Safety of One Dose Of RG2077 (CTLA4-IgG4m) in Patients With Relapsing-Remitting Multiple Sclerosis
Conditions: Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
Efficacy and Safety Evaluation of Allergen Immunotherapy Co-Administered With Omalizumab, an Anti-IgE Monoclonal Antibody
Conditions: Hay Fever; Hypersensitivity; Allergy; Rhinitis
Evaluation of a Diabetes Vaccine in Newly Diagnosed Type I Diabetics
Conditions: Insulin-Dependent Diabetes Mellitus; Diabetes Mellitus
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of NBI-5788 in Patients with Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis
The AIRIA Study: Allergen-immunostimulatory sequences for ragweed-induced asthma
Conditions: Asthma, ragweed allergy (hay fever)
Renal Allograft Tolerance Through Mixed Chimerism
Conditions: Kidney Failure; Kidney Transplantation; Kidney Failure, Chronic
Combined HLA-matched Bone Marrow and Kidney Transplantation for Multiple Myeloma with Renal Failure
Conditions: Kidney transplantation; Kidney Failure, Chronic; Multiple Myeloma
Campath-1H/Tacrolimus/Sirolimus Withdrawal in Renal Transplantation
Condition: Kidney Transplantation
Treating Systemic Lupus Erythematosus Patients with CTLA4-IgG4m (RG2077)
Conditions: Lupus Erythematosus, Systemic; Lupus Nephritis
In addition, current listings of clinical trials for many, many conditions, please visit: www.clinicaltrials.gov or check the Other Resources section for more information on enrolling in clinical trials.
|
